Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: Its relation to omalizumab treatment
MEDICAL SCIENCE MONITOR, cilt.18, sa.3, 2012 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 18 Sayı: 3
- Basım Tarihi: 2012
- Doi Numarası: 10.12659/msm.882504
- Dergi Adı: MEDICAL SCIENCE MONITOR
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Anahtar Kelimeler: severe persistent allergic asthma, allergic asthma, soluble TRAIL, omalizumab, RHEUMATOID-ARTHRITIS, APOPTOSIS, RHINITIS, STRAIL, CELLS, EXPRESSION, SURVIVAL, LIGAND, DEATH, FAS
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Çukurova Üniversitesi Adresli: Hayır
Özet
Background: In this study we compare the Omalizumab treatment modality in the dynamics of cell apoptosis regulating molecules in both severe persistent asthma patients who had no other any allergic disease, newly diagnosed patients with allergic asthma, and healthy volunteers.